NEW YORK, July 21, 2017 -- According to market research “Global Molecular Biology Kits & Reagents and Enzymes Market Size, Share, Development, Growth and Demand Forecast to 2022 – Industry Insights by Product (Kits & Reagents and Enzymes), by Application (Polymerase Chain Reaction, Sequencing, Cloning, Epigenetic, Restriction Digestion, Synthetic Biology and Others), by End User (Academic & Research Institute, Hospital & Diagnostic Center, Pharmaceutical & Biotechnology Company and Others)” by P&S Market Research, the global molecular biology kits and reagents and enzymes market was valued at $4,928.3 million in 2015 and it is expected to grow at a CAGR of 17.2% during 2016 - 2022. The molecular biology kits and reagents and enzymes market is growing due to increasing geriatric population, increasing prevalence of infectious diseases, and growing cases with genetic disorders. In addition, increasing healthcare expenditure resulting in improvement in research activities is further driving the market growth.
Browse Detailed Information on Molecular Biology Kits & Reagents and Enzymes Market: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market
Based on product, kits and reagents accounted for the largest market in the global market in 2015, and it is expected to witness 17.7% CAGR during 2016 – 2022. Among the various applications, sequencing segment is expected to witness the fastest growth during the forecast period. Whereas, the end user hospital segment is expected to witness the fastest growth during the forecast period.
Geographically, North America has been globally the largest market of molecular biology kits and reagents and enzymes, owing to the improvement in research and development activities and increasing cases with genetic disorders in the region. Furthermore, increase in number of pharmaceutical and biotechnology companies are also driving the market growth in this region. However, the molecular biology kits and reagents and enzymes market is expected to witness fastest growth in Asia-Pacific, with a CAGR of 17.8% during the forecast period. The high growth is attributed to increasing awareness about molecular biology kits and reagents and enzymes and increasing cases with molecular diagnostics in the region.
Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market/report-sample
Molecular biology kits and reagents and enzymes helps in detecting specific sequences in DNA or RNA. In addition, they help in detection of infectious diseases, genetic disease screening, human leukocyte antigen typing, extraction and purification of nucleic acid and detection of amplified nucleic acid. However, the high cost of molecular biology kits and reagents and enzymes as well the privacy issues related to genetic information act as the key restraints in the growth of the market. High cost of these kits and reagents and enzymes limits the affordability of the users, and hampering the growth of the market.
Some of the competitors in the global molecular biology kits & reagents and enzymes market are Thermo Fisher Scientific, Inc., Merck KGAA, Qiagen N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Promega Corporation, New England Biolabs, Inc., Illumina, Inc. and Takara Bio Inc.
Browse Related Research at:
Single-Cell Analysis Market
The growing geriatric population across the globe are expected to increase the demand for single-cell analysis products. The geriatric population is more vulnerable to infections and immunological diseases, which is having high positive impact on market growth. According to UN report, the number of people aged 60 years or over is projected to grow by 56% from 901 million in 2015 to reach 1.4 billion, globally by 2030. It further reported that by 2050 the global geriatric population is expected to more than double of its size than in 2015, reaching nearly 2.1 billion. Thus, the growing incidence of geriatric population is driving the growth of this market.
https://www.psmarketresearch.com/market-analysis/single-cell-analysis-market
Medical Gases and Equipment Market
The global medical gases and equipment market is growing at a significant rate, due to growing geriatric population, increasing prevalence of respiratory diseases, and increasing prevalence of lifestyle associated diseases. In addition, the technological advancement, and increasing demand for home healthcare are also driving the growth of the global market. However, the restraints associated with the growth of the global medical gases and equipment market includes shortage of helium and change in medical gas calibration standards.
https://www.psmarketresearch.com/market-analysis/medical-gases-and-equipment-market
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Contact:
Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google Plus | Facebook


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



